Perioperative and long-term outcomes of utilizing donation after circulatory death liver grafts with macrosteatosis: A multicenter analysis
| Autor: | Peter A. Senada, Bashar Aqel, Adyr A. Moss, Charles B. Rosen, Julie K. Heimbach, C. Burcin Taner, Jacob Piatt, Kristopher P. Croome, Amit K. Mathur, Shennen A. Mao |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Brain Death
medicine.medical_specialty Tissue and Organ Procurement medicine.medical_treatment 030230 surgery Liver transplantation Gastroenterology 03 medical and health sciences 0302 clinical medicine Internal medicine medicine Long term outcomes Humans Immunology and Allergy Pharmacology (medical) Retrospective Studies Transplantation business.industry Graft Survival Arizona Acute kidney injury Patient survival Perioperative medicine.disease Circulatory death Tissue Donors Death Stenosis Treatment Outcome Liver Florida Steatosis business |
| Zdroj: | American Journal of Transplantation. 20:2449-2456 |
| ISSN: | 1600-6135 |
| DOI: | 10.1111/ajt.15877 |
| Popis: | BACKGROUND Given the potentially additive risk from using donor livers that are both steatotic and from a donation after circulatory death (DCD) donor, there is a paucity of data on the outcome of DCD liver transplantation (LT) utilizing livers with macrosteatosis. METHODS All DCD LT performed at Mayo Clinic-Florida, Mayo Clinic-Arizona, and Mayo Clinic-Rochester from 1999 to 2019 were included (N = 714). Recipients of DCD LT were divided into 3 groups: those with moderate macrosteatosis (30%-60%), mild macrosteatosis (5%-30%), and no steatosis ( |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text